SCHEMBL24192809

SCHEMBL24192809

Nc1ccc(CN2CCN(C3CCC3)CC2)c(C(F)(F)F)c1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.66
ALDH1A1 P00352 4/20 0.56
KDM4E B2RXH2 3/20 0.56
ATM Q13315 1/20 0.41
POLB P06746 1/20 0.40
HRH3 Q9Y5N1 2/20 0.40
CHRM1 P11229 3/20 0.40
ACHE P22303 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
DDR1 Q08345 1/20 0.40
TP53 P04637 1/20 0.39
DRD2 P14416 1/20 0.39
ADORA1 P30542 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
TRPV6 Q9H1D0 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29958956 0.95 NR1H2 (0.69) NR1H2ALDH1A1KDM4EATMPOLB
SCHEMBL274890 0.95 NR1H2 (0.69) NR1H2ALDH1A1KDM4EATMPOLB
SCHEMBL24192814 0.89 NR1H2 (0.58) NR1H2ALDH1A1KDM4EDDR1
SCHEMBL27088110 0.86 NR1H2 (0.64) NR1H2ALDH1A1KDM4EATMPOLB
SCHEMBL24191963 0.85 NR1H2 (0.66) NR1H2ALDH1A1KDM4EATMPOLB
SCHEMBL4933173 0.83 NR1H2 (0.76) NR1H2ALDH1A1KDM4EATMPOLB
SCHEMBL545052 0.83 NR1H2 (0.76) NR1H2ALDH1A1KDM4EATMPOLB
SCHEMBL15688033 0.83 NR1H2 (0.60) NR1H2ALDH1A1KDM4EATMPOLB
SCHEMBL29998843 0.82 NR1H2 (0.74) NR1H2ALDH1A1KDM4EATMPOLB
SCHEMBL3166705 0.82 NR1H2 (0.74) NR1H2ALDH1A1KDM4EATMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022008383-A1 ISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES GALAPAGOS NV (BE) 2022-01-13 WO disclosed